Two years after its founding at the Technical University of Munich (TUM), the Munich School of BioEngineering (MSB) is expanding its scope of action: The upcoming opening of the MSB-associated Central Institute for Translational Cancer Research (TranslaTUM) will give physicists, engineers and physicians a shared new laboratory building for transdisciplinary research in the midst of the TUM’s Klinikum rechts der Isar in Munich. In addition, a new structure for the Bavarian NMR Center (BNMRZ) will soon open on the Garching campus. The new building for protein research, expected to be finished in two years and also located in Garching, completes the most topically diverse bio-engineering structure in all of Europe. The new construction represents an investment of more than 135 million Euros, half of which is being financed by the German Federal Government. Leibniz Prize winner Prof. Franz Pfeiffer (44) will succeed the founding director Prof. Axel Haase as of April 1, 2017.